Health | WPN World People News

Outbreaks of Cryptosporidium (Crypto) in the United States increased an average 13% each year from 2009-2017, according to a report published in CDC’s Morbidity and Mortality Weekly Report.

The CDC recommends that everyone between the ages of 13 – 64 years be screened at least once in their lifetime, yet less than 40% of people in the U.S. have ever been tested for HIV, according to a CDC report published today in the Morbidity and Mortality Weekly Report (MMWR).

Mogadishu, 25 June 2019 - Health authorities rolled out a polio campaign yesterday in Puntland and Somaliland to vaccinate more than 940 000 children under 5 years of age to stop an ongoing outbreak of a strain of poliovirus.

The number of people at risk of trachoma – the world’s leading infectious cause of blindness – has fallen from 1.5 billion in 2002 to just over 142 million in 2019, a reduction of 91%, WHO has reported.

Elevated blood pressure in the first trimester of pregnancy, or an increase in blood pressure between the first and second trimesters, raises the chances of a high blood pressure disorder of pregnancy, according to a study.

Scanning electron micrograph of Mycobacterium tuberculosis bacteria, which cause TB.

WHO launched a global campaign urging governments to adopt a tool to reduce the spread of antimicrobial resistance, adverse events and costs.

Three quarters of people living with epilepsy in low-income countries do not get the treatment they need, increasing their risk of dying prematurely and condemning many to a life of stigma.

Retinal sections from a patient with retinitis pigmentosa show microglia (green) migrating into the photoreceptor layer (blue) once degeneration had begun. Inset shows microglia expressing C3 (red), which occurred in the context of photoreceptor degeneration. NEI

Research supported by the Accelerating Medicines Partnership (AMP) on Rheumatoid Arthritis and Systemic Lupus Erythematosus (RA/SLE) provides new insights into tissue damage for these autoimmune conditions. Findings include the identification of novel molecular signatures related to immune system signaling in kidney cells that may reflect their active role in disease process; molecular targets, including specific white blood cells, for potential treatment in lupus nephritis; and specific types of fibroblasts and white blood cells that are involved in rheumatoid arthritis. These discoveries set the stage for uncovering potential drug target candidates that could advance to experimental treatments. Results of the studies were published on June 18, 2019.